skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Refracture of the tibia 6 years after bilateral tibia nail removal in a patient later diagnosed with osteopetrosis

Case report

(1397) Views  (867) Full article downloads

Authors: Joost H van Linge, JHJM Gert Bessems, P Koen Bos

Published Date September 2010 Volume 2010:3 Pages 93 - 98
DOI: http://dx.doi.org/10.2147/OAS.S10841

Joost H van Linge1,2, JHJM Gert Bessems1 , P Koen Bos1

1Department of Orthopaedic Surgery, Erasmus MC, Rotterdam, the Netherlands; 2Reinier de Grant Gasthuis, Ga Delft, the Netherlands

Abstract: Osteopetrosis is a rare bone disease with a high fracture incidence and a risk for recurrent fractures. We describe a case report of an adult female with a refracture of her right tibia 6 years after routine bilateral tibia nail removal. The patient and 3 of her family members had a history of multiple (stress) fractures. Later we diagnosed autosomal dominant osteopetrosis in our patient and her family. In addition we give an overview of osteopetrosis and our considerations regarding routine removal of intramedullary implants in these patients.

Keywords: fracture, stress fracture, pathological fracture, intramedullary nailing






Readers of this article also read:

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Robotic surgery: applications and cost effectiveness
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum